ALAIN SCHREIBER
CIK 1225149 · last filed 2017-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.46M
Companies
5
Total Filings
26
Lifetime Open-Market Net
-$4.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 18,477 | $2.14 | $39.5K | -$18.94M | 5 | 2017-04-27 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | 10%+ Owner | 4,668,663 | $1.51 | $7.05M | $28.50M | 1 | 2015-01-23 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | 10%+ Owner | 8,100,034 | — | — | -$13.84M | 4 | 2009-10-13 |
| NVD | 10%+ Owner | 6,267,570 | $5.02 | $31.46M | $2.79M | 3 | 2008-12-23 |
| CADENCE PHARMACEUTICALS INC (CADX) Delisted | Director | 3,013,269 | — | — | -$2.70M | 3 | 2007-09-04 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-08-13 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Sell (S) | −1,788,240 | -$6.40M | EDGAR |
| 2009-03-06 | — | Buy (P) | +457,666 | $0 | |
| 2009-01-12 | — | Grant (A) | — | $0 | |
| 2008-12-23 | NVD | Buy (P) | — | $0 | EDGAR |
| 2008-10-10 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +354,174 | $174.6K | EDGAR |
| 2008-09-10 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Buy (P) | +639,006 | $594.4K | EDGAR |
| 2008-07-22 | — | Buy (P) | +943,396 | $8.00M | |
| 2008-06-25 | NVD | Buy (P) | — | $0 | EDGAR |
| 2007-12-06 | — | Grant (A) | — | $0 | |
| 2007-09-14 | — | Grant (A) | +2,500 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.